Clinical trial
Effectiveness of Nasal Budesonide on Control of Airway Inflammation by Determining FeNO in Children With Allergic Rhinitis.
NCT02409563 is registered in ClinicalTrials.gov with Istituto per la Ricerca e l'Innovazione Biomedica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Nasal Budesonide on Control of Airway Inflammation by Determining FeNO in Children With Allergic Rhinitis.
- Lead sponsor
- Istituto per la Ricerca e l'Innovazione Biomedica
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- March 31, 2014
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allergic rhinitis